Akshay Vaishnaw, EVP, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 11,000 shares at $75.00 ($825K) on 2017-05-23, disclosed to the SEC on 2017-05-25.
Open-market sale of $825k ALNY by EVP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |